BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16828555)

  • 1. Role of glutamine 148 of human 15-hydroxyprostaglandin dehydrogenase in catalytic oxidation of prostaglandin E2.
    Cho H; Huang L; Hamza A; Gao D; Zhan CG; Tai HH
    Bioorg Med Chem; 2006 Oct; 14(19):6486-91. PubMed ID: 16828555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key NAD+-binding residues in human 15-hydroxyprostaglandin dehydrogenase.
    Cho H; Hamza A; Zhan CG; Tai HH
    Arch Biochem Biophys; 2005 Jan; 433(2):447-53. PubMed ID: 15581601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threonine 188 is critical for interaction with NAD+ in human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
    Zhou H; Tai HH
    Biochem Biophys Res Commun; 1999 Apr; 257(2):414-7. PubMed ID: 10198228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding human 15-hydroxyprostaglandin dehydrogenase binding with NAD+ and PGE2 by homology modeling, docking and molecular dynamics simulation.
    Hamza A; Cho H; Tai HH; Zhan CG
    Bioorg Med Chem; 2005 Jul; 13(14):4544-51. PubMed ID: 15908215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-directed mutagenesis of the conserved serine 138 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase to an alanine results in an inactive enzyme.
    Ensor CM; Tai HH
    Biochem Biophys Res Commun; 1996 Mar; 220(2):330-3. PubMed ID: 8645305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threonine 11 of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase may interact with NAD(+) during catalysis.
    Cho H; Tai HH
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(5-6):505-9. PubMed ID: 12144871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates.
    Zhou H; Yan F; Tai HH
    Eur J Biochem; 2001 Jun; 268(12):3368-74. PubMed ID: 11422365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
    Ensor CM; Tai HH
    Biochim Biophys Acta; 1994 Sep; 1208(1):151-6. PubMed ID: 8086429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical residues for the coenzyme specificity of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase.
    Cho H; Oliveira MA; Tai HH
    Arch Biochem Biophys; 2003 Nov; 419(2):139-46. PubMed ID: 14592457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cysteine 182 is essential for enzymatic activity of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase.
    Ensor CM; Tai HH
    Arch Biochem Biophys; 1996 Sep; 333(1):117-20. PubMed ID: 8806761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed mutagenesis of active site residues of phosphite dehydrogenase.
    Woodyer R; Wheatley JL; Relyea HA; Rimkus S; van der Donk WA
    Biochemistry; 2005 Mar; 44(12):4765-74. PubMed ID: 15779903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human L-xylulose reductase holoenzyme: probing the role of Asn107 with site-directed mutagenesis.
    El-Kabbani O; Ishikura S; Darmanin C; Carbone V; Chung RP; Usami N; Hara A
    Proteins; 2004 May; 55(3):724-32. PubMed ID: 15103634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.
    Tai HH; Cho H; Tong M; Ding Y
    Curr Pharm Des; 2006; 12(8):955-62. PubMed ID: 16533162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.
    Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T
    PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of human prostaglandin F synthase (AKR1C3).
    Komoto J; Yamada T; Watanabe K; Takusagawa F
    Biochemistry; 2004 Mar; 43(8):2188-98. PubMed ID: 14979715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catalytic reaction and inhibition mechanism of Drosophila alcohol dehydrogenase: observation of an enzyme-bound NAD-ketone adduct at 1.4 A resolution by X-ray crystallography.
    Benach J; Atrian S; Gonzàlez-Duarte R; Ladenstein R
    J Mol Biol; 1999 Jun; 289(2):335-55. PubMed ID: 10366509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalytic triad in Drosophila alcohol dehydrogenase: pH, temperature and molecular modelling studies.
    Winberg JO; Brendskag MK; Sylte I; Lindstad RI; McKinley-McKee JS
    J Mol Biol; 1999 Nov; 294(2):601-16. PubMed ID: 10610783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of 15-hydroxyprostaglandin dehydrogenase catalytic reaction mechanism by molecular dynamics simulations.
    Al-Najjar BO
    J Mol Graph Model; 2018 Mar; 80():190-196. PubMed ID: 29414038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-directed mutagenesis of the conserved tyrosine 151 of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme.
    Ensor CM; Tai HH
    Biochem Biophys Res Commun; 1991 Apr; 176(2):840-5. PubMed ID: 2025296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active site directed mutagenesis of 3 beta/17 beta-hydroxysteroid dehydrogenase establishes differential effects on short-chain dehydrogenase/reductase reactions.
    Oppermann UC; Filling C; Berndt KD; Persson B; Benach J; Ladenstein R; Jörnvall H
    Biochemistry; 1997 Jan; 36(1):34-40. PubMed ID: 8993315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.